Oxepa

Especially suitable for inflammatory and hyper-inflammatory situations in patients with critical pathologies, which must be artificially ventilated and/or are affected by sepsis, SIRS (Systemic Inflammatory Response Syndrom) or ALI (Acute Lung Injury)/ARDS (Acute Respiratory Distress Syndrome).

Description
Produced for balanced enteral nutrition, hypercaloric (1.5 kcal/ml), low carbohydrate content, with a high percentage of eicosapentaenoic acid (EPA), gamma-linoleic acid (GLA) and antioxidants.
EPA and GLA fatty acids have anti-inflammatory properties and positively influence the inflammatory reaction.
Antioxidants neutralize free radicals and protect against oxidative processes.
Low percentage of carbohydrates, which minimizes CO2 production.

Format
Bottle 500 ml.

Cod. M648